Tilray (NASDAQ:TLRY) Shares Up 3.8%

Tilray Inc (NASDAQ:TLRY)’s share price was up 3.8% during trading on Tuesday . The company traded as high as $1.80 and last traded at $1.79. Approximately 6,988,291 shares traded hands during mid-day trading, a decline of 76% from the average daily volume of 29,137,781 shares. The stock had previously closed at $1.72.

Wall Street Analyst Weigh In

TLRY has been the topic of several recent analyst reports. Canaccord Genuity Group reduced their target price on shares of Tilray from $4.25 to $4.00 and set a “buy” rating on the stock in a research note on Wednesday, April 10th. CIBC decreased their price objective on shares of Tilray from $2.25 to $2.00 and set a “neutral” rating for the company in a report on Wednesday, April 10th. Finally, Alliance Global Partners lifted their price target on shares of Tilray from $2.25 to $2.75 and gave the company a “neutral” rating in a research note on Friday, April 5th.

Tilray Trading Up 8.0 %

The company has a 50 day moving average of $1.95 and a two-hundred day moving average of $1.95. The stock has a market capitalization of $1.44 billion, a PE ratio of -4.06 and a beta of 2.36. The company has a debt-to-equity ratio of 0.11, a quick ratio of 1.18 and a current ratio of 1.92.

Hedge Funds Weigh In On Tilray

Several institutional investors have recently made changes to their positions in TLRY. McAdam LLC increased its stake in shares of Tilray by 66.1% during the first quarter. McAdam LLC now owns 48,261 shares of the company’s stock worth $119,000 after purchasing an additional 19,207 shares in the last quarter. PFG Investments LLC purchased a new position in shares of Tilray in the first quarter worth about $319,000. Madrona Financial Services LLC acquired a new position in Tilray during the first quarter worth about $124,000. HighPoint Advisor Group LLC acquired a new stake in Tilray in the 4th quarter valued at about $43,000. Finally, Austin Wealth Management LLC purchased a new position in Tilray in the 4th quarter worth approximately $115,000. 9.35% of the stock is owned by hedge funds and other institutional investors.

Tilray Company Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.